Bioleaders Corporation Market Cap ($2.60 Million)

$2.60 Million USD · ₩3.84 Billion KRW · Rank #29700

Market Cap & Net Worth: Bioleaders Corporation (142760)

Bioleaders Corporation market cap. Bioleaders Corporation (KQ:142760) has a market capitalization of $2.60 Million (₩3.84 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #29700 globally and #2092 in its home market, demonstrating a -63.60% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioleaders Corporation's stock price ₩182.00 by its total outstanding shares 21083490 (21.08 Million). Also see 142760 cash flow conversion for how efficiently the company converts equity into cash flow.

Bioleaders Corporation Market Cap History (2016–2026)

Bioleaders Corporation market cap history from 2016 to 2026. Data shows change from $79.10 Million to $2.60 Million (-33.72% CAGR). Check Bioleaders Corporation stock quote for real-time trading data and today's change.

Index Memberships

Bioleaders Corporation is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$211.91 Billion	0.00%	#1148 of 1384
Kosdaq Composite Index KQ11	$211.91 Billion	0.00%	#1148 of 1384

Weight: Bioleaders Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Bioleaders Corporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Bioleaders Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Bioleaders Corporation growing its equity to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.00x

Bioleaders Corporation's market cap is 0.00 times its annual revenue

Industry average: 4493.50x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$79.10 Million	$2.50 Billion	-$5.90 Billion	0.03x	N/A
2017	$127.44 Million	$7.61 Billion	-$6.65 Billion	0.02x	N/A
2018	$158.34 Million	$86.07 Billion	-$17.23 Billion	0.00x	N/A
2019	$90.13 Million	$72.88 Billion	-$28.05 Billion	0.00x	N/A
2020	$90.16 Million	$80.45 Billion	-$21.14 Billion	0.00x	N/A
2021	$119.30 Million	$101.17 Billion	-$19.77 Billion	0.00x	N/A
2022	$51.01 Million	$100.41 Billion	-$23.14 Billion	0.00x	N/A
2023	$30.43 Million	$18.25 Billion	$8.01 Billion	0.00x	0.00x
2024	$17.27 Million	$15.63 Billion	-$6.99 Billion	0.00x	N/A
2025	$25.36 Million	$11.22 Billion	-$13.05 Billion	0.00x	N/A

Competitor Companies of 142760 by Market Capitalization

Companies near Bioleaders Corporation in the global market cap rankings as of November 4, 2026. Also see 142760 asset base for a full breakdown of the balance sheet.

Key companies related to Bioleaders Corporation by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#180	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$553.15
#372	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$961.26
#411	CSL Ltd	AU:CSL	$69.05 Billion	AU$201.16
#497	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$220.83

Market Capitalization of Bioleaders Corporation (2016–2026)

Market capitalization of Bioleaders Corporation from 2016 to today. Between 2016 and today, Bioleaders Corporation's market cap moved from $79.10 Million to $ 2.60 Million, with a yearly change of -33.72%.

Year	Market Cap	Change (%)
2026	₩2.60 Million	-89.75%
2025	₩25.36 Million	+46.82%
2024	₩17.27 Million	-43.24%
2023	₩30.43 Million	-40.34%
2022	₩51.01 Million	-57.25%
2021	₩119.30 Million	+32.33%
2020	₩90.16 Million	+0.03%
2019	₩90.13 Million	-43.08%
2018	₩158.34 Million	+24.25%
2017	₩127.44 Million	+61.10%
2016	₩79.10 Million	--

End of Day Market Cap According to Different Sources

On Nov 3rd, 2026 the market cap of Bioleaders Corporation was reported to be:

Source	Market Cap
Yahoo Finance	$2.60 Million USD
MoneyControl	$2.60 Million USD
MarketWatch	$2.60 Million USD
marketcap.company	$2.60 Million USD
Reuters	$2.60 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$2.60 Million

₩3.84 Billion KRW

Market Cap Rank

#29700 Global

#2092 in Korea

Share Price

₩182.00

Change (1 day)

-17.27%

52-Week Range

₩182.00 - ₩1850.00

All Time High

₩24990.00